Health Canada Submission Management

Listing Websites about Health Canada Submission Management

Filter Type:

Guidance Document: The Management of Drug Submissions and …

(8 days ago) 1.1 Purpose/overviewThe Guidance Document: Management of Drug Submissions and Applications (MSDA) gives sponsors and Health Canada staf… See more

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/management-drug-submissions/industry/document.html

Category:  Health Show Health

Guidance Document: The Management of Drug Submissions and …

(9 days ago) WEBTelephone: 613-957-0368. Fax: 613-952-7756. Teletypewriter: 1-800-465-7735 (Service Canada) E-mail: pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca. Date modified: 2022-08-02. 2005 Health Canada guidance document providing clarification of the way in which Health Canada manages information and material …

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/management-drug-submissions/industry.html

Category:  Health Show Health

Guidance document : management of drug submissions and …

(1 days ago) WEBOttawa, ON : Health Canada = Santé Canada, July 2021. ©2021 : Description : 1 online resource (72 pages) ISBN : 9780660393704 : Catalogue number : H164-277/2021E-1-PDF; Subject terms : Drug approval -- Canada. Pharmaceutical policy -- Canada.

https://publications.gc.ca/site/eng/9.901130/publication.html

Category:  Health Show Health

Guidance document : the management of drug submissions and …

(1 days ago) WEBPublication information; Department/Agency : Canada. Health Canada, issuing body. Title : Guidance document : the management of drug submissions and applications.

https://publications.gc.ca/site/eng/9.912786/publication.html

Category:  Health Show Health

Guidance Document

(2 days ago) WEBHealth Canada Address Locator 0900C2 Ottawa, ON K1A 0K9 Tel.: 613‐957‐2991 Toll free: 1‐866‐225‐0709 Fax: 613‐941‐5366. TTY: 1‐800‐465‐7735. E‐mail: publications@hc‐sc.gc.ca. Her Majesty the Queen in Right of Canada, as represented by the Minister of Health, 2019.

https://publications.gc.ca/collections/collection_2021/sc-hc/H164-271-2019-eng.pdf

Category:  Health Show Health

Health Canada updates Guidance Document: The Management of …

(9 days ago) WEBAuthored by Katie Lee. September 30, 2019. On July 25, 2019, Health Canada released an updated version of the Guidance Document: The Management of Drug Submissions and Applications. The updates follow from an earlier consultation and reflect updated processes and procedures related to filing a submission or application …

https://www.smartbiggar.ca/insights/publication/health-canada-updates-guidance-document-the-management-of-drug-submissions-and-applications

Category:  Health Show Health

Regulatory submissions and transactions with Health Canada

(8 days ago) WEBStarting January 1, 2020, all regulatory transactions for Master Files prepared in the non-eCTD format must be sent via the Common Electronic Submission Gateway (CESG). We have seen a spike in these types of submissions. The CESG has been in operation at Health Canada since February 2014, and it provides a secure and …

https://www.certara.com/blog/regulatory-submissions-and-transactions-with-health-canada/

Category:  Health Show Health

Health Canada: Guidance Document Management of Drug …

(9 days ago) WEBHealth Canada on August 2, 2022, revised the Guidance Document entitled: The Management of Drug Submissions and Applications (MDSA).This guidance provides guidance regarding the way in which drug submissions, applications or post-market documents submitted to Health Canada are managed. It outlines and describes the …

https://www.regulatoryaffairsnews.com/post/health-canada-guidance-document-management-of-drug-submissions-and-applications-post-din-changes

Category:  Health Show Health

Health Canada Implementation of ICH Q12: CMC Changes

(Just Now) WEB– Health Canada recommends that the PLCM document be provided in tabular format in eCTD section 3.2.R.8, with specific references to the submission sequence, eCTD section number, and page number where each EC’s scientific justification can be found. – An updated PLCM document should be included in post-approval …

https://www.casss.org/docs/default-source/cmc-strategy-forum-north-america/2021-cmc-na-speaker-presentations/hamel-hugo-health-canada-2021.pdf?sfvrsn=9db6e87d_8

Category:  Health Show Health

Health Canada updates Guidance Document: The Management of …

(Just Now) WEBOn July 25, 2019, Health Canada released an updated version of the Guidance Document: The Management of Drug Submissions and Applications. The updates follow from an earlier consultation and

https://www.jdsupra.com/legalnews/health-canada-updates-guidance-document-46662/

Category:  Health Show Health

Publication of the Health Canada Guidance Document: Quality …

(2 days ago) WEBPublication of the Health Canada Guidance Document: Quality (Chemistry and Manufacturing) Guidance: New Drug Submissions (NDSs) and Abbreviated New Drug Submissions (ANDSs) Significant new requirements are presented in the guidance document (i.e. stability studies on three batches of product for existing drugs, …

https://open.canada.ca/data/en/info/89e44fc0-5ead-423b-a518-b6bf2e604c02

Category:  Health Show Health

Applications and submissions – Drug products - canada.ca

(2 days ago) WEBProduct Vigilance. Veterinary Drugs Application and Submission Guidance Documents. Date modified: 2024-01-02. Health Canada guidance documents to assist in the interpretation of policies and governing statutes and regulations when preparing drug submissions when seeking an approval to sell a drug product in Canada.

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents.html

Category:  Health Show Health

The Drug Review and Approval Process in Canada – An eGuide

(Just Now) WEBIn addition, Life Cycle Management activities (post approval submissions to Health Canada, for new indications, new dosage forms, new strengths, manufacturing changes, etc.) are required to ensure the maintenance of the product License with its related improvements. In summary, sponsors need to ensure its continued compliance with the …

https://spharm-inc.com/the-drug-review-and-approval-process-in-canada-an-eguide/

Category:  Health Show Health

Management of Drug Submissions - FDAnews

(6 days ago) WEBHealth Canada Management of Drug Submissions Guidance for Industry 2 Does not apply to combinations of drugs and medical devices where the two drug components and/or drug and device components can be used separately (that is, products sold together in procedure packages and trays). Revised Date: 2013/12/19; Effective Date: 2013/12/19 3 3.

https://www.fdanews.com/ext/resources/files/01/01-13-CanadianSubmissions.pdf

Category:  Medical Show Health

Guidance Document Regarding Administrative Processing of …

(3 days ago) WEBHealth Canada recently published a guidance document to clarify the requirements for eligible drug submissions and applications processed under the administrative pathway. The document replaces the Changes in Manufacturer's Name and/or Product Name Policy (CMPN), written in 1998 and updated in 2001, 2015 and 2017.

https://capra.ca/en/blog/guidance-document-regarding-administrative-processing-of-submissions-and-applications-human-or-disinfectant-drugs-2019-04-23.htm

Category:  Health Show Health

Strategies for Filing Efficient Submissions - CAPRA

(3 days ago) WEBThe Cover Letter should clearly indicate the reason for the filing and relevant pre-submission correspondence with Health Canada should be referenced (as well as included in Module 1). It should be indicated if the submission is being filed in response to an Advisement Letter; a copy of the letter should also be provided in Module 1.0.3.

https://capra.ca/_uploads/5dd407959141a.pdf

Category:  Health Show Health

Health Canada Drug Labelling, NDS & Drug Submissions in 2023

(7 days ago) WEBProposed Changes to Labelling of Pharmaceutical Drugs for Human Use: Health Canada launched a consultation on a proposal to amend the labeling of pharmaceutical drugs for a human use guidance document on December 21, 2022. The proposed changes were to sections C.01.004 (1) (a) and C.01.011 of the Food and Drug …

https://qualitysmartsolutions.com/news/health-canada-guidance-drug-labelling-nds-rolling-reviews/

Category:  Food Show Health

Digital therapeutics (DTx) for disease management McKinsey

(9 days ago) WEBWithin digital health, funding for digital therapeutics (including solutions for mental health) has grown at an even faster pace—up 134 percent from the prior year to reach $8.9 billion in 2021. 2. The impact potential here is significant, both in terms of clinical outcomes and economic benefits for stakeholders and societies.

https://www.mckinsey.com/industries/life-sciences/our-insights/the-health-benefits-and-business-potential-of-digital-therapeutics

Category:  Health Show Health

Advancing Parkinson's Disease Research in Canada: The Canadian …

(1 days ago) WEBBackground: Enhancing the interactions between study participants, clinicians, and investigators is imperative for advancing Parkinsons disease (PD) research. The Canadian Open Parkinson Network (C-OPN) stands as a nationwide endeavor, connecting the PD community with ten accredited universities and movement disorders research …

https://www.medrxiv.org/content/10.1101/2024.05.10.24307196v1

Category:  Health Show Health

Guidance Document

(2 days ago) WEBHealth Canada recognizes that: i. any change to a drug may impact the safety, efficacy and quality of that drug, and ii. any change to the information associated with the drug (e.g., labelling) may impact the safe and effective use of that drug. To enable Health Canada to manage risks that may be associated with a change to a new drug: i.

https://publications.gc.ca/collections/collection_2021/sc-hc/H13-9-31-2019-eng.pdf

Category:  Health Show Health

National Incidence, Outcomes, and Management Strategies for …

(1 days ago) WEBBackground: Among heart transplant candidates, atrial fibrillation (AF) is a common comorbidity; however, little is known about the impact of pre-transplant AF on incidence of post-transplant AF or other transplant outcomes. Methods: Adult heart transplant recipients transplanted from 07/01/2012 to 07/01/2021 with data available in …

https://www.medrxiv.org/content/10.1101/2024.05.14.24307382v1

Category:  Health Show Health

Guidance Document - canada.ca

(8 days ago) WEBManagement of Drug Submissions and Applications Date Adopted: 2020/11/26 Revised Posted: 2022/08/02 Effective Date: 2022/08/02 . Guidance Document: Management of Drug Submissions & Applications 2 Health Canada is responsible for helping Canadians maintain and improve their health. It ensures that high-quality health services are …

https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/management-drug-submissions/industry/guidance-document-management-drug-submissions-applications.pdf

Category:  Health Show Health

Federal Register :: Submission for Office of Management and …

(7 days ago) WEBSubmission for Office of Management and Budget Review; Head Start REACH: Strengthening Outreach, Recruitment, and Engagement Approaches With Families-Mixed Methods Study (New Collection) within the U.S. Department of Health and Human Services (HHS) is proposing to collect data on different approaches that …

https://www.federalregister.gov/documents/2024/05/15/2024-10578/submission-for-office-of-management-and-budget-review-head-start-reach-strengthening-outreach

Category:  Health Show Health

Guidance Document

(6 days ago) WEBManagement of Drug Submissions and Applications Date Adopted: November 26, 2020 Revised Posted: 2021/05/21 Effective Date: 2021/05/21 . Guidance Document: Management of Drug Submissions & Applications 2 Health Canada is responsible for helping Canadians maintain and improve their health. It

https://www.publications.gc.ca/collections/collection_2021/sc-hc/H164-277-2021-eng.pdf

Category:  Health Show Health

Guidance Document - Submission of Risk Management Plans and …

(2 days ago) WEBSponsors should also refer to the Health Canada guidance document titled Management of Drug Submissions for instructions on how to request pre-submission meetings. Sponsors should forward their pre-submission meeting requests to the appropriate Directorate (Office) located within Health Canada, please refer to Appendix 1 for …

https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/guidance-document-submission-risk-management-plans-follow-commitments.html

Category:  Health Show Health

Agency Information Collection Activities; Submission for OMB …

(6 days ago) WEBStart Preamble ACTION: Notice of availability; request for comments. SUMMARY: The Department of Labor (DOL) is submitting this Mine Safety and Health Administration (MSHA)-sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the …

https://www.federalregister.gov/documents/2024/05/14/2024-10425/agency-information-collection-activities-submission-for-omb-review-comment-request-proximity

Category:  Health Show Health

Drug and Health Product Submissions Under Review (SUR)

(3 days ago) WEBThe Submissions Under Review (SUR) Lists include new drug submissions containing new active substances (pharmaceuticals and biologics with an active ingredient not approved in Canada). This applies to submissions accepted for review on or after April 1, 2015. The lists also include submissions accepted for review on or after May 1, 2016

https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/submissions-under-review.html

Category:  Health Show Health

Food insecurity is associated with poor hypertension management …

(1 days ago) WEBBackground Limited evidence exists on the association between food insecurity (FI) and blood pressure control in the Caribbean despite the high burden of both. The objective of this study is to examine the relationship between FI and hypertension prevalence, awareness, and control in the Eastern Caribbean. Methods and Findings …

https://www.medrxiv.org/content/10.1101/2024.05.14.24307353v1

Category:  Food Show Health

Innovating Urban Mosquito Control: Introducing Human …

(1 days ago) WEBThis study introduces a novel method for mosquito control tailored specifically for urban and suburban areas, addressing their unique challenges. The concept of Human-Controlled Breeding Sites (HCBS) is presented as an innovative approach to reducing mosquito populations by providing controlled oviposition sites within households. The …

https://www.medrxiv.org/content/10.1101/2024.05.14.24307332v1

Category:  Health Show Health

Register Of Innovative Drugs Products for Human Use - Active …

(8 days ago) WEBSubmission Number Innovative Drug Manufacturer Drug(s) Containing the Medicinal Ingredient / Variations Notice of Compliance Date yyyy-mm-dd 6 Year "No File" efinaconazole 159416 Jublia Bausch Health, Canada Inc. N/A 2013-10-02 2019-10-02 N/A 2021-10-02 Page 24 of 43 2024-05-09. Products for Human Use - Expired Data …

https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/drug-products/applications-submissions/register-innovative-drugs/reg-innov-dr-eng-10-may-2024.pdf

Category:  Health Show Health

Filter Type: